Hoxb5 transcription factor converts B lymphoid cells to functional T cells, avoiding tumorigenesis risk inherent in hematopoietic lineage master regulators.
A chimeric cytokine receptor fuses inhibitory binding domains with stimulatory signaling ends to redirect immune cell activation pathways.
Measuring Fkbp10 and ZdhhC6 expression via qRT-PCR identifies productive CHO clones early, reducing cultivation time compared to traditional long-term assays.
GSK3β and TGF-β inhibitors drive pluripotent stem cells into satellite-like cells, resolving the inefficiency of multi-step derivation processes.